Kamali Mahdieh, Hantoushzadeh Sedigheh, Borna Sedigheh, Neamatzadeh Hossein, Mazaheri Mahta, Noori-Shadkam Mahmood, Haghighi Fatemeh
Department of Perinatology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Maternal-Fetal and Neonatal Research Center, Tehran University of Medical Sciences, Tehran, Iran
Iran Biomed J. 2018 Mar;22(2):78-89. doi: 10.22034/ibj.22.2.78. Epub 2017 Jul 23.
Studies have indicated that thrombophilic genes polymorphisms are associated with recurrent pregnancy loss (RPL) in the Iranian population. However, the results from these studies remained inconsistent and inconclusive. The aim of this systematic review and meta-analysis was to evaluate the precise association between thrombophilic genes polymorphisms (MTHFR C677T, MTHFR A1298C, Prothrombin G20210A, FVL G1691A, and PAI-1 4G/5G) and RPL risk in the Iranian population.
Electronic databases of PubMed, Web of Science, Google Scholar, and ISC were searched for eligible articles published up to April 1, 2017. The association between genetic polymorphisms and RPL risk was measured by ORs with 95% CI.
A total of 37 case-control studies in 18 relevant publications were selected in the final meta-analysis, including 1,199 RPL cases and 1,079 controls for MTHFR C677T, 1,194 RPL cases and 1079 controls for MTHFR A1298C, 630 RPL cases and 594 controls for Prothrombin G20210A, 830 RPL cases and 794 controls for FVL G1691A, and 955 RPL cases and 499 controls for PAI-1 4G/5G. When all the eligible studies were pooled into the meta-analysis of MTHFR C677T and A1298C polymorphisms, a significant increased risk of RPL was observed in all genetic models in the population. In addition, Prothrombin G20210A (in allelic and dominant models), FVL G1691A (in allelic and dominant model), and PAI-1 4G/5G (in allelic, homozygote, dominant and recessive genetic models) polymorphisms were associated with RPL risk in the Iranian population.
The findings suggest that the thrombophilic genes polymorphisms are associated with an increased RPL risk in the Iranian population.
研究表明,血栓形成倾向基因多态性与伊朗人群复发性流产(RPL)相关。然而,这些研究结果仍不一致且无定论。本系统评价和荟萃分析的目的是评估血栓形成倾向基因多态性(MTHFR C677T、MTHFR A1298C、凝血酶原G20210A、FVL G1691A和PAI-1 4G/5G)与伊朗人群RPL风险之间的确切关联。
检索了PubMed、Web of Science、Google Scholar和ISC的电子数据库,以查找截至2017年4月1日发表的符合条件的文章。基因多态性与RPL风险之间的关联通过具有95%置信区间的比值比(OR)来衡量。
最终的荟萃分析共纳入了18篇相关出版物中的37项病例对照研究,其中MTHFR C677T有1199例RPL病例和1079例对照,MTHFR A1298C有1194例RPL病例和1079例对照,凝血酶原G20210A有630例RPL病例和594例对照,FVL G1691A有830例RPL病例和794例对照,PAI-1 4G/5G有955例RPL病例和499例对照。当将所有符合条件的研究纳入MTHFR C677T和A1298C多态性的荟萃分析时,在该人群的所有遗传模型中均观察到RPL风险显著增加。此外,凝血酶原G20210A(等位基因和显性模型)、FVL G1691A(等位基因和显性模型)以及PAI-1 4G/5G(等位基因、纯合子、显性和隐性遗传模型)多态性与伊朗人群的RPL风险相关。
研究结果表明,血栓形成倾向基因多态性与伊朗人群RPL风险增加相关。